A Closer Look at FDA’s Newly Released AI/ML Action Plan
FDA’s new Action Plan takes steps toward establishing a dedicated regulatory strategy for AI products intended as software as a medical device.

FDA’s new Action Plan takes steps toward establishing a dedicated regulatory strategy for AI products intended as software as a medical device.
Deep phenotyping offers the criminal justice system the tools to improve public safety, identify low-risk offenders, and reduce recidivism.
Researchers will need to consider when it is appropriate to leverage AI, versus when a human touch is needed.
This digital symposium explores the ethical, legal, and social implications of advances in deep phenotyping in psychiatry research.